Cut MLR Review
From 40 Days to 14
Content Velocity for FDA-Regulated Markets
The MLR Bottleneck
Is Costing You Millions
40-Day Review Cycles
Average MLR review takes 40 days. Legal reviewers average 8.2 days per asset due to competing priorities.
68,000+ FDA Submissions
Massive volume creates bottlenecks. Every piece requires compliance verification and reference validation.
$60M Monthly Impact
Content bottleneck costs $60M in lost NPV for every month of launch delay. Market windows close.
Autonomous MLR
Compliance Checking
The Quome Difference: Our platform autonomously checks for off-label statements, validates risk information, and ensures 100% reference annotation—all mapped to PI pages, clinical studies, and source literature.
Real-Time Error Detection
AI identifies compliance issues before human review begins, eliminating revision cycles.
Reference Validation
Automatic mapping to PI pages, clinical studies, and source literature with full traceability.
Concurrent Workflows
Medical, Legal, and Regulatory can review simultaneously instead of sequentially.
Enterprise-Grade
Compliance Platform
Built for FDA-Regulated Content
- Off-label statement detection with regulatory context
- Risk information completeness verification
- Modular content libraries for reuse
- Form FDA 2253 submission ready
- Complete audit trail for every change
- SOC 2 Type II compliant infrastructure
Proven Results
Across Pharma Leaders
Case Study: A top-10 pharmaceutical company reduced their promotional content cycle from 6-8 weeks to under 3 weeks, enabling them to respond to competitive launches 2x faster than before.